ArticleAlzheimer's & dementia (New York, N. Y.)2018

A randomized, single ascending dose study of intravenous BIIB092 in healthy participants.

Irfan A Qureshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.